Responses
Regular and Young Investigator Award Abstracts
Checkpoint Blockade Therapy
480 Translational PK/RO model of tetravalent bispecific antibody CTX8371: receptor occupancy estimation, PD1 loss and bispecific binding-related avidity increase in low doses
Compose a Response to This Article
Other responses
No responses have been published for this article.
